ArticlePLoS neglected tropical diseases2026
Analysis of the consultations on the InfoChagas digital platform.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople affected by T cruzi infection, and at risk to develop Chagas disease, face significant barriers to accessing healthcare and often lack adequate information and communication resources. To address this, the Chagas Coalition developed the InfoChagas digital platform, including an informative website and consultations sections, linked YouTube channels in English and Spanish. METHODOLOGY: This cross-sectional study analyzed consultations to the InfoChagas platform between 2016 and 2023. We conducted quantitative and qualitative analyses of the consultants' profiles, enquiry topics, and barriers that people at risk of having T. cruzi infection faced when seeking health care. PRINCIPAL
findingsA total of 272 consultations were received via the website (n = 129) and YouTube (n = 143) from 19 endemic and non-endemic countries. Nearly two-thirds of these were from Argentina (n = 33, 25.6%), Mexico (n = 24, 18.6%), and Bolivia (n = 22, 17%). Main topics included doubts related to access to treatment (n = 71, 26%), transmission risk in daily life (n = 38, 14%) and requests for help or referrals to health care professionals (n = 38, 14%). Half of the users (n = 138, 50.7%) reported barriers to healthcare access, with the majority citing the inability of the system to provide adequate and effective care for T. cruzi infection (n = 127, 92.7%). Additionally, 96.7% (n = 270) of the narratives highlighted the need for information, education, and communication (IEC) to understand the complexity of T. cruzi infection and to demystify concepts that hinder access to healthcare. CONCLUSIONS/SIGNIFICANCE: InfoChagas serves as an informative, communicative, educational, and supportive resource for individuals affected by or at risk of T. cruzi infection across diverse geographic regions. Given the critical role of IEC strategies and the rise of healthcare technology, digital tools such as InfoChagas is a useful resource to face the existing barriers to healthcare access for the infection and to improve access to quality information and healthcare services.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.